GlassScriptPhysician profile
Haritha Babburi
NPI 1750560793
$497.46
in general payments reported to CMS, 2019-2025
10 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.80 · 2023: $27.52 · 2024: $113 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $159.87 | 2024-2025 | Triclip |
| Edwards Lifesciences Corporation | $126.87 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $75.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.83 | 2024 | |
| Cvrx, INC. | $25.22 | 2024 | Barostim Neo System |
| Heartflow, INC. | $20.28 | 2025 | |
| Alnylam Pharmaceuticals INC. | $16.95 | 2023 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.51 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $14.13 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Babburi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.